NANOG and breast carcinoma: ALKBH5 demethylates m6A marks from NANOG, a master pluripotency factor; the oxidative demethylation activity of the ALKBH5 increases the NANOG transcript and protein expression that enriches breast cancer stem cells in the reduced oxygen tumor microenvironment promoting cancer progression (Zhang et al., 2016a).